Cherry Creek Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,752
Closed -$350K – 121
2025
Q1
$350K Hold
2,752
– – 0.18% 79
2024
Q4
$396K Hold
2,752
– – 0.19% 71
2024
Q3
$410K Hold
2,752
– – 0.21% 66
2024
Q2
$347K Sell
2,752
-895
-25% -$140K 0.18% 78
2024
Q1
$671K Sell
3,647
-483
-12% -$92K 0.36% 48
2023
Q4
$743K Sell
4,130
-261
-6% -$40.6K 0.45% 39
2023
Q3
$698K Hold
4,391
– – 0.47% 40
2023
Q2
$621K Sell
4,391
-332
-7% -$53.2K 0.42% 43
2023
Q1
$795K Hold
4,723
– – 0.58% 35
2022
Q4
$800K Sell
4,723
-18
-0.4% -$3.27K 0.62% 36
2022
Q3
$887K Hold
4,741
– – 0.74% 35
2022
Q2
$770K Buy
4,741
+40
+0.9% +$6.33K 0.62% 41
2022
Q1
$884K Hold
4,701
– – 0.58% 40
2021
Q4
$1.25M Hold
4,701
– – 0.77% 40
2021
Q3
$1.36M Hold
4,701
– – 0.9% 36
2021
Q2
$938K Buy
+4,701
New +$912K 0.62% 44

Other funds holding RGEN

Cherry Creek Investment Advisors's RGEN Position: Q2 2025 in Review

Cherry Creek Investment Advisors sold out of Repligen (RGEN) in Q2 2025, closing a stake of 2,752 shares — an estimated $350K sold.

Cherry Creek Investment Advisors first reported a position in RGEN in Q2 2021 and held it in 16 quarters. The position peaked at $1.36M in Q3 2021. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Cherry Creek Investment Advisors reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Cherry Creek Investment Advisors sold 2,752 Repligen shares in Q2 2025, an estimated $350K.
  • Cherry Creek Investment Advisors first reported a position in Repligen in Q2 2021 and held it in 16 quarters.
  • Cherry Creek Investment Advisors's Repligen position peaked at $1.36M in Q3 2021.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.